Description
99% Dutasteride Hormones steroid raw powder CAS 164656-23-9 for hair loss treatment
Description
Name: | Dutasteride | CAS No.: | 164656-23-9 |
---|---|---|---|
Molecular Formula: | C27H30F6N2O2 | Molecular Weight: | 528.53 |
EINECS NO.: | 638-758-5 | Appearance: | White Or Off White Powder |
COA: | Available |
99% Dutasteride Hormones steroid raw powder CAS 164656-23-9 for hair loss treatment
Physical Characters and specifications
Product name | Dutasteride |
CAS No. | 164656-23-9 |
Molecular Formula | C27H30F6N2O2 |
Molecular weight | 528.53 |
EINECS NO. | 638-758-5 |
Grade Standard | Medicine Grade |
COA | Avaliable |
Item | Specifications |
Appearance | White or off white powder |
Purity | 99%min |
Melting point | 242-250℃ |
Specific rotation | [α]/D +18 to +24°, c = 1 in chloroform-d |
MOQ | 10g |
Solubility | DMSO: soluble2mg/mL, clear |
Stability | Stable. Combustible. Incompatible with strong oxidizing agents. |
Storage condition | -20℃ |
Shelf life | 2 years |
Product Introduction
Dutasteride is useful for the symptoms of benign prostatic hyperplasia (BPH); colloquially known as an “enlarged prostate”.
In those who are being regularly screened 5-alpha-reductase inhibitor(finasteride and dutasteride) reduce the overall risk of being diagnosed with prostate cancer however there is insufficient data to determine if they have an effect on the risk of death and may increase the chance of more serious cases.
Function
Benign prostatic hyperplasia
Physicians use finasteride for the treatment of BPH, informally known as an enlarged prostate. The FDA-approved dose is 5 mg once a day. Six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment. If the drug is discontinued, any therapeutic benefits reverse within about –8 months. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow.
Male pattern baldness
Finasteride is used to treat male pattern hair loss (androgenetic alopecia) in men only. Treatment provides about 30% improvement in hair loss after six months of treatment, and effectiveness only persists as long as the drug is taken.
Off-label uses
Finasteride is sometimes used in hormone replacement therapy for male-to-female transsexuals in combination with a form of estrogen due to its antiandrogen properties. However, little clinical research of finasteride use for this purpose has been conducted and evidence of efficacy is limited.
Application
Treatment of swollen Prostate
Male pattern hair loss
Seborrheic hair loss
Inherited hair loss